Mutual funds holding Zydus Lifesciences shares
124 mutual fund schemes held Zydus Lifesciences shares in their latest portfolios (October 2026, or September 2026 where a fund house's October 2026 portfolio is not yet in), worth about ₹8,400 cr in all. The largest holders by value are Parag Parikh Flexi Cap Fund (1.6% of the fund), Kotak Flexi Cap Fund (2.3% of the fund), HSBC Midcap Fund (3.8% of the fund).
Against the month before, 5 schemes added Zydus Lifesciences as a new holding and 0 sold out of it completely.
New holders: SBI Flexicap Fund, SBI Healthcare Opportunities Fund, WhiteOak Capital Special Opportunities Fund, Baroda BNP Paribas Large and Mid Cap fund, Samco Multi Cap Fund
By category: Index Fund (53), Sectoral/Thematic (23), Flexi Cap (8), Large & Mid Cap (7), Value / Contra (6), Mid Cap (5).
5 actively managed schemes holding it are rated A+ or A on their track record, among them HSBC Midcap Fund, Quant ELSS Tax Saver Fund, HSBC Large & Mid Cap Fund, HDFC Pharma and Healthcare Fund, SBI Healthcare Opportunities Fund.
Every scheme holding Zydus Lifesciences, by value
And 84 more schemes with smaller holdings.
Value: the scheme's assets under management × the stock's weight, approximate. Change: the weight against the previous month's portfolio, in percentage points; it moves with the share price as well as with buying and selling. Links go to each scheme's Regular plan.
Common questions
How many mutual funds hold Zydus Lifesciences shares?
124 schemes held Zydus Lifesciences in their latest monthly portfolios (October 2026, or September 2026 where a fund house's October 2026 portfolio is not yet in), worth about ₹8,400 cr in all.
Which mutual fund holds the most Zydus Lifesciences shares?
By value, Parag Parikh Flexi Cap Fund: about ₹2,393 cr, 1.63% of the fund.
Where does this data come from?
From the monthly portfolios that every fund house must publish by the 10th of the following month. Values are approximate: the fund's assets under management multiplied by the stock's weight in the portfolio.
This page lists which funds hold a stock. It is not a view on the stock or a recommendation to buy or sell it or any fund. Ratings describe past track records, not a forecast.
Send us your CAS and get a written report: which of your funds to keep, which to exit and when, where new SIPs should go, and what each change costs in tax.